Local search, the device enables owners to tap into an always up-to-date database of local information, rendering obsolete the war over which device has the most millions of points-of-interest.
Schering-Plough has changed the start date listed in a government database for the key clinical trial testing the now-controversial cholesterol pill Vytorin, which Schering shares with Merck .